Filtered By:
Specialty: Cancer & Oncology
Source: Oncotarget
Cancer: Brain Cancers
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke.
In conclusion, xenogenic ADMSC/ADMSC-derived exosome therapy was safe and offered the additional benefit of reducing BIZ and improving neurological function in rat AIS.
PMID: 27793019 [PubMed - as supplied by publisher]
Source: Oncotarget - October 31, 2016 Category: Cancer & Oncology Tags: Oncotarget Source Type: research
